Implementation of ELN within Synthon ... - PerkinElmer

More documents

Recommendations

Info

SYNTHON’S STRATEGIC DIRECTION IS TOWARD SPECIALTY PHARMACEUTICALS Synthon is on a path toward becoming a recognized global leader in specialty pharmaceuticals for auto-immune diseases / multiple sclerosis and oncology. Synthon
SYNTHON COMPLETED NEW WORLD CLASS BIOPHARMACEUTICAL LABS Located at Synthon Headquarters in Nijmegen, Netherlands New Labs opened in April, 2011 • 6850m 2 gross area • 2x 1000m 2 lab floor • 131 working places • 2400 m 2 offices • 800 m 2 GMP warehouse Synthon
Page 1 and 2: CROSS-DISCIPLINE IMPLEMENTATION OF
Page 3 and 4: A SHORT INTRODUCTION • Bonnie Sch
Page 5: SYNTHON IS WELL ESTABLISHED WITH A
Page 9 and 10: HISTORY OF ELN WITHIN SYNTHON Situa
Page 11 and 12: HISTORY OF ELN WITHIN SYNTHON (3) J
Page 13 and 14: CONTENTS • A short introduction
Page 15 and 16: ELN CONFIGURATION WITHIN SYNTHON (2
Page 17 and 18: ELN CONFIGURATION WITHIN SYNTHON (4
Page 19 and 20: CONTENTS • A short introduction
Page 21 and 22: IMPLEMENTATION OF ELN WITHIN SYNTHO
Page 29: THE FUTURE • On short term: • S

Implementation of ELN within Synthon ... - PerkinElmer

Create successful ePaper yourself

Delete template?

Save as template?